Werbung
Werbung

CNMD

CNMD logo

CONMED Corporation

43.40
USD
Gesponsert
-0.08
-0.19%
07. Jan., 16:00 UTC -5
Geschlossen
exchange

Vor-Markt

43.41

+0.01
+0.02%

CNMD Ergebnisberichte

Positives Überraschungsverhältnis

CNMD übertreffen die 29 der letzten 39Schätzungen.

74%

Nächster Bericht

Datum des nächsten Berichts
28. Jan. 2026
Estimate for Q4 25 (Revenue/ EPS)
$374.13M
/
$1.34
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+10.71%
/
+24.07%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+8.15%
/
--

CONMED Corporation earnings per share and revenue

On 05. Nov. 2025, CNMD reported earnings of 1.08 USD per share (EPS) for Q3 25, beating the estimate of 1.07 USD, resulting in a 0.66% surprise. Revenue reached 337.93 million, compared to an expected 341.45 million, with a -1.03% difference. The market reacted with a -0.52% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 1.34 USD, with revenue projected to reach 374.13 million USD, implying an increase of 24.07% EPS, and increase of 10.71% in Revenue from the last quarter.
FAQ
For Q3 2025, CONMED Corporation reported EPS of $1.08, beating estimates by 0.66%, and revenue of $337.93M, -1.03% below expectations.
The stock price moved down -0.52%, changed from $44.44 before the earnings release to $44.21 the day after.
The next earning report is scheduled for 28. Jan. 2026.
Based on 8 analysts, CONMED Corporation is expected to report EPS of $1.34 and revenue of $374.13M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung